← Open Payments lookup

AMARACHI IHEMEDU: Open Payments

NPI 1992309561 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,332 in 200 payments from 13 companies in 2025. Trend: 2023 $405 · 2024 $3,319 · 2025 $4,332

Food & beverage: $4,220Education: $111
CompanyPaymentsAmount
ABBVIE INC.60$1,157
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$614
Neurocrine BioSciences, Inc.19$419
Teva Pharmaceuticals USA, Inc.15$393
E.R. Squibb & Sons, L.L.C.14$378
Vanda Pharmaceuticals Inc.14$351
Janssen Pharmaceuticals, Inc10$278
Otsuka America Pharmaceutical, Inc.15$274
Lundbeck LLC10$168
Supernus Pharmaceuticals, Inc.14$152

Products named: VRAYLAR, CAPLYTA, INGREZZA, REXULTI, COBENFY, INVEGA SUSTENNA, AUSTEDO XR, HETLIOZ.

Industry payments across CA — which companies pay providers there.